UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neutrophil‐to‐lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710

Cancer, 2017-03, Vol.123 (5), p.794-801

2017

Volltextzugriff (PDF)

Accuracy of Smoking Status Reporting

Mayo Clinic proceedings. Innovations, quality & outcomes, 2020-12, Vol.4 (6), p.801-809

2020

Volltextzugriff (PDF)

MP34-05 VARIATION IN URINARY MICROBIOTA OF ASTRONAUTS ON A SHORT DURATION SPACE FLIGHT

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

Predictive biomarkers for response to immunotherapy in patients with deficient DNA mismatch repair metastatic colorectal cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.254-254

2023

Volltextzugriff (PDF)

Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients

European journal of cancer (1990), 2024-11, Vol.212, p.114336, Article 114336

2024

Volltextzugriff (PDF)

Childhood Exposure to Low to Moderate Doses of Ionizing Radiation and the Risk of Vascular Diseases: The Tinea Capitis Study

American journal of epidemiology, 2021-03, Vol.190 (3), p.423-430

2021

Volltextzugriff (PDF)

Su1323 - The Cost-Effectiveness of a Novel Risk-Tailored Sequential Pancreatic Cancer Screening Strategy Among New-Onset Diabetes

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-520-S-520

2018

Volltextzugriff (PDF)

Su1268 - The Influence of Proton Pump Inhibitors on Pancreatic Cancer Risk and Survival after Diagnosis

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S496-S496

2017

Volltextzugriff (PDF)

Tu1362 - Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S896-S896

2017

Volltextzugriff (PDF)

Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16167-e16167

2023

Volltextzugriff (PDF)

Impact of antibiotics (ABX) on overall survival (OS) in patients (pts) with advanced non-small-cell lung cancer (aNSCLC) and melanoma (aMel) treated with first-line immune checkpoint inhibition (ICI)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20643-e20643

2019

Volltextzugriff (PDF)

Benefit of oxaliplatin in stage III colon cancer according to IDEA risk groups: Analysis of MOSAIC and C-07 trials

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.118-118

2020

Volltextzugriff (PDF)

Sa1071 - Statin Use at the Time of Intra-Abdominal Surgery Reduces the Risk of Post-Operative Small Bowel Obstruction and Adhesion-Related Complications: A Populationrepresentative Cohort Study

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-229-S-230

2018

Volltextzugriff (PDF)

Combination treatment of intratumoral vidutolimod (CMP-001), radiosurgery, nivolumab, and ipilimumab for metastatic colorectal carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.123-123

2023

Volltextzugriff (PDF)

Apollo: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1 , BRCA2 , or PALB2 mutation—ECOG-ACRIN EA2192

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS4202-TPS4202

2023

Volltextzugriff (PDF)

APOLLO: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2 or PALB2 mutation—ECOG-ACRIN EA2192

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS763-TPS763

2023

Volltextzugriff (PDF)

The association between allopurinol use and urologic malignancies: A nested case-control study

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.435-435

2020

Volltextzugriff (PDF)

The impact of pancreatic cancer resection in the era of effective systemic treatment

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.722-722

2020

Volltextzugriff (PDF)

Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” Eur J Cancer. 2023 Jan;178:162–170

European journal of cancer (1990), 2023-11, Vol.194, p.113339-113339, Article 113339

2023

Volltextzugriff (PDF)

396 The Effect of Past Antibiotic Exposure on Diabetes Risk

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-84-S-84

2015

Volltextzugriff (PDF)

Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort Study

Journal of the National Comprehensive Cancer Network, 2024-09, p.1-7

2024

Volltextzugriff (PDF)

The Influence of Proton Pump Inhibitors on Pancreatic Cancer Risk and Survival after Diagnosis

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S496-S496

2017

Volltextzugriff (PDF)

Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S896-S896

2017

Volltextzugriff (PDF)

Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma

Journal of cancer research and clinical oncology, 2022-07, Vol.148 (7), p.1709-1709

2022

Volltextzugriff (PDF)

Effect of pectasol-c modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in non- metastatic biochemically relapsed prostate cancer (BRPC) patients (pts): Primary outcome analysis of a prospective phase II study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16609-e16609

2019

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(80)

Sprache

Englisch
(79)
Hebräisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Neutrophil‐to‐lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710

Accuracy of Smoking Status Reporting

MP34-05 VARIATION IN URINARY MICROBIOTA OF ASTRONAUTS ON A SHORT DURATION SPACE FLIGHT

Predictive biomarkers for response to immunotherapy in patients with deficient DNA mismatch repair metastatic colorectal cancer

Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients

Childhood Exposure to Low to Moderate Doses of Ionizing Radiation and the Risk of Vascular Diseases: The Tinea Capitis Study

Su1323 - The Cost-Effectiveness of a Novel Risk-Tailored Sequential Pancreatic Cancer Screening Strategy Among New-Onset Diabetes

Su1268 - The Influence of Proton Pump Inhibitors on Pancreatic Cancer Risk and Survival after Diagnosis

Tu1362 - Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study

Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data

Impact of antibiotics (ABX) on overall survival (OS) in patients (pts) with advanced non-small-cell lung cancer (aNSCLC) and melanoma (aMel) treated with first-line immune checkpoint inhibition (ICI)

Benefit of oxaliplatin in stage III colon cancer according to IDEA risk groups: Analysis of MOSAIC and C-07 trials

Sa1071 - Statin Use at the Time of Intra-Abdominal Surgery Reduces the Risk of Post-Operative Small Bowel Obstruction and Adhesion-Related Complications: A Populationrepresentative Cohort Study

Combination treatment of intratumoral vidutolimod (CMP-001), radiosurgery, nivolumab, and ipilimumab for metastatic colorectal carcinoma

Apollo: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1 , BRCA2 , or PALB2 mutation—ECOG-ACRIN EA2192

APOLLO: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2 or PALB2 mutation—ECOG-ACRIN EA2192

The association between allopurinol use and urologic malignancies: A nested case-control study

The impact of pancreatic cancer resection in the era of effective systemic treatment

Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” Eur J Cancer. 2023 Jan;178:162–170

396 The Effect of Past Antibiotic Exposure on Diabetes Risk

Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort Study

The Influence of Proton Pump Inhibitors on Pancreatic Cancer Risk and Survival after Diagnosis

Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study

Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma

Effect of pectasol-c modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in non- metastatic biochemically relapsed prostate cancer (BRPC) patients (pts): Primary outcome analysis of a prospective phase II study

Aktive Filter

Suchergebnisse filtern